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E-mail: asoriano@clinic.ub.esTABLE 1. Differences observed between Duijf et al. study and
Tornero et al. study
Duijf et al. [1]
(n [ 44)
Tornero et al. [2]a
(n [ 74) p
Mean age (years) 71 69
Male sex 16 (36%) 27 (37%) 0.85
Risk factorsb
Diabetes mellitus 8 (18%) 13 (19%) 0.86
Rheumatoid arthritis 3 (7%) 3 (4%) 0.81
Location
Hip 28 (64%) 55 (74%) 0.30
Knee 16 (36%) 18 (24%)
Other 0 (0%) 1 (1%)
Enterococcus faecium (%) — 7 (9%)
Polymicrobial infection 35 (80%) 48 (65%) 0.13
Mean follow-up (days) 678 681
Outcome
Retention after DAIR 29 (66%) 46 (62%)
Failure 15 (34%) 28 (38%) 0.83
aData from Tornero et al. [2] study were modiﬁed: only prosthetic joint infections
<90 days after index surgery treated with debridement, implant retention and
antibiotics (DAIR) were selected and outcome was evaluated after 2 years of follow
up.
bData were only available in 69 cases of the Tornero et al. study.Sir,
We read with great interest the results of Duijf et al. [1] of a
consecutive group of patients with an early prosthetic joint
infection (PJI) with Enterococcus spp. treated with debridement,
implant retention and antibiotics (DAIR).
We agree with the authors that a standardized protocol for
the management of early PJI is fundamental for achieving good
results after DAIR procedures and the differences in success
rate observed between our multi-national study [2] and Duijf
et al. [1] study (66% versus 48%) could be explained by dif-
ferences in the treatment protocol. However, other factors
may be involved in the discrepancy observed in success rates
between both studies.
Duijf et al. [1] presented a very interesting retrospective
study of 44 patients who underwent primary or revision joint
replacement arthroplasty between 2009 and 2013 and devel-
oped a PJI due to Enterococcus spp. In our study, 94 out of 178
cases were treated with DAIR. According to the data from
Duijf et al. [1], there were no differences between the studies
regarding the percentage of male sex (36% versus 38%), prev-
alence of diabetes mellitus (18% versus 20%) or rheumatoid
arthritis (7% versus 5%); however, there are some important
differences. They only included early (<90 days from index
surgery) PJI and the mean follow-up period was 678 days (range
140–1642 days). Among the 94 patients treated with DAIR in
our study, 48 patients had an early infection (<30 days after
index surgery), 38 an intermediate infection (between 30 days
and 2 years after index surgery) and eight a late infection (>2Clinical Microbiology and Infection © 2015 European Society of Cyears after index surgery) and the mean follow-up period was
1348 days (range 357–5126 days).
These factors may partly explain the differences observed in
success rate between both studies, so we analysed our data
considering similar patients. Those PJIs diagnosed within the
ﬁrst 90 days from index surgery, treated with DAIR, and with 2
years of follow up were reviewed. We identiﬁed 74 patients
with a mean age of 69 years (range 25 to 93) and a mean follow
up of 681 days. Debridement was performed at an average of
28 days after the index implantation. In 48 cases (65%) the
infection was polymicrobial. At the last follow up, 46 patients
(62%) were in remission and the prosthesis was not removed
and 28 patients were considered as failure (according to the
criteria described in the original article). Differences observed
between both studies are shown in Table 1.
We agree with Duijf et al. [1] that a standard protocol for
the treatment of PJIs, particularly those caused by difﬁcult-to-
treat pathogens like Enterococcus spp., is essential. To
compare results, it is very important to evaluate patients with
similar characteristics, most especially in terms of the time from
arthroplasty to infection diagnosis when debridement is the
surgical approach [3]. Interestingly, selecting similar cases our
cohorts were similar in age, sex, location, polymicrobial infec-
tion and failure rate. A success rate between 62 and 66% is far
from the 88% success rate obtained in staphylococcal infections
treated with DAIR and a combination of levoﬂoxacin and
rifampin [4]. Therefore, it is necessary to answer important
clinical questions like the role of rifampin combinations [2],
fosfomycin [5], linezolid [6] or new glycolipopeptides that are
very active against enterococci [7]. To do this, collaborative
platforms such us the European Study Group in InfectionsClin Microbiol Infect 2015; 21: e43–e44
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